PT003 MDI Dose Confirmation Study

Clinical trial NCT01349816 · COMPLETED

Trial details

NCT number: NCT01349816
Sponsor: Pearl Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease

Start date: 2011-06-01
Primary completion: 2011-11-01
Enrollment: 185

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.